Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands

被引：1

作者：

Zhong, Hui ^{[1
]}

Jiang, Qi ^{[1
]}

Wu, Cong ^{[1
]}

Yu, Huanghe ^{[1
,2
]}

Li, Bin ^{[1
,2
]}

Zhou, Xudong ^{[1
,2
]}

Fu, Ronggeng ^{[1
]}

Wang, Wei ^{[1
,2
]}

Sheng, Wenbing ^{[1
,2
]}

机构：

[1] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China

[2] Hunan Univ Chinese Med, TCM & Ethnomed Innovat & Dev Int Lab, Changsha 410208, Peoples R China

来源：

MOLECULES | 2024年 / 29卷 / 02期

关键词：

artemisinin; bivalent ligands; multi-target molecular docking; antitumor target protein; antitumor activity; BRIDGED PORPHYRINS; IN-VITRO; CANCER; ANTIMALARIAL; DERIVATIVES; POTENT; DIMERS; BCL-2; MECHANISMS; EXPRESSION;

D O I：

10.3390/molecules29020409

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Five artemisinin bivalent ligands molecules 4a-4e were designed, synthesized, and confirmed by 1H NMR, 13C NMR, and low-resolution mass spectrometry, and the bioactivities of the target compounds were investigated against four human tumor cell lines in vitro, including BGC-823, HepG-2, MCF-7, and HCT-116. The results showed 4a, 4d, and 4e exhibited significantly tumor cell inhibitory activity compared with the artemisinin and dihydroartemisinin; compound 4e has good biological activity inhibiting BGC-823 with an IC50 value of 8.30 mu mol/L. Then, the good correlations with biological results were validated by molecular docking through the established bivalent ligands multi-target model, which showed that 4e could bind well with the antitumor protein MMP-9.

引用

页数：14

共 50 条

[41] Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives
Mao, Long-fei
Wang, Zhen-Zhen
Wu, Qiong
Chen, Xiaojie
Yang, Jian-Xue
Wang, Xin
Li, Yue-Ming
FRONTIERS IN PHARMACOLOGY, 2022, 13
[42] Design, synthesis and antitumor activity of icotinib derivatives
Mao, Longfei
Sun, Ge
Zhao, Jie
Xu, Guiqing
Yuan, Miaomiao
Li, Yue-Ming
BIOORGANIC CHEMISTRY, 2020, 105
[43] Design, synthesis and pharmacological evaluation of novel Artemisinin-Thymol
Kavak, Emrah
Mutlu, Dogukan
Ozok, Omruye
Arslan, Sevki
Kivrak, Arif
NATURAL PRODUCT RESEARCH, 2022, 36 (14) : 3511 - 3519
[44] Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D2-Like Receptors and the -Opioid Receptor
Qian, Mingcheng
Vasudevan, Lakshmi
Huysentruyt, Jelle
Risseeuw, Martijn D. P.
Stove, Christophe
Vanderheyden, Patrick M. L.
Van Craenenbroeck, Kathleen
Van Calenbergh, Serge
CHEMMEDCHEM, 2018, 13 (09) : 944 - 956
[45] Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines
Chao, Bo
Li, Bingbing X.
Xiao, Xiangshu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (14) : 3107 - 3110
[46] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF THE ANTICONVULSANT ACTIVITY OF BIVALENT LIGANDS DERIVED FROM 4-AMINO-2',6'-DIMETHYLBENZANILIDE
POUPAERT, JH
HERMANS, E
JONCKHEERE, Y
MERGEN, F
LAMBERT, D
LEROT, T
AANDRIANJARA, R
POUPAERT, EJ
LYBRAND, T
DURANT, F
ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1990, 5 (03): : 249 - 251
[47] Synthesis and antitumor activity evaluation of chrysin derivatives
Zhu, Zhen-Yuan
Wang, Wan-Xiao
Wang, Zhen-qian
Chen, Li-Jing
Zhang, Jing-Yi
Liu, Xiao-cui
Wu, Shao-ping
Zhang, Yong-min
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 75 : 297 - 300
[48] Synthesis of aristolactam analogues and evaluation of their antitumor activity
Choi, Young Lok
Kim, Joa Kyum
Choi, Sang-Un
Min, Yong-Ki
Bae, Myung-Ae
Kim, Bum Tae
Heo, Jung-Nyoung
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) : 3036 - 3040
[49] Ester tethered artemisinin-isatin hybrids: design, synthesis and anti-leukemic activity evaluation
Wang, Peng
Yuan, Dai
Wang, Weiwei
Zhou, Lei
Wang, Lin
Zhao, Yang
Xu, Jiarui
Kong, Li
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (11) : 2376 - 2379
[50] Ester tethered artemisinin-isatin hybrids: design, synthesis and anti-leukemic activity evaluation
Peng Wang
Dai Yuan
Weiwei Wang
Lei Zhou
Lin Wang
Yang Zhao
Jiarui Xu
Li Kong
Medicinal Chemistry Research, 2023, 32 : 2376 - 2379

← 1 2 3 4 5 →